This finding was further confirmed by flow cytometric analysis and TUNEL assay, as more apoptotic CD138+ MM cells were observed in the bone marrow of adipocyte-EZH2 knockout mice than those in wild-type mice after bortezomib treatment (Fig. 8g and h). This evidence concerns the gene SDC1 and Miyoshi myopathy.